Skip to main content
ClinicalTrials.govcontrolled

Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD

ClinicalTrials.gov study NCT03386474. IPD Sharing: YES. Countries: 2. Publications: 0.

ShareScore

32/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship
16
Harmonization
8
Access
4
Reuse readiness
0
Engagement
4

Topics